The multifaceted therapeutical role of low‐density lipoprotein receptor family in high‐grade glioma

2024-9-14

<scp>ERK</scp>1/2 mitogen‐activated protein kinase dimerization is essential for the regulation of cell motility

2024-9-12

Enhancing immunotherapy through <scp>PD</scp>‐<scp>L</scp>1 upregulation: the promising combination of anti‐<scp>PD</scp>‐<scp>L</scp>1 plus m<scp>TOR</scp> inhibitors

2024-9-11

Targeting the <scp>CLK</scp>2/<scp>SRSF</scp>9 splicing axis in prostate cancer leads to decreased <scp>ARV</scp>7 expression

2024-9-11

<scp>KRAS^G</scp>^{12<scp>C</scp>}‐inhibitor‐based combination therapies for pancreatic cancer: insights from drug screening

2024-9-10

Patient‐derived acellular ascites fluid affects drug responses in ovarian cancer cell lines through the activation of key signalling pathways

2024-9-8

Tumor and α‐<scp>SMA</scp>‐expressing stromal cells in pancreatic neuroendocrine tumors have a distinct <scp>RNA</scp> profile depending on tumor grade

2024-9-8

Simultaneous detection of eight cancer types using a multiplex droplet digital <scp>PCR</scp> assay

2024-9-6

A method to quantitatively characterize the formation and dissociation of tumor cell clusters using light transmission aggregometry

2024-9-5

<i>KRAS</i> and <i>GNAS</i> mutations in cell‐free <scp>DNA</scp> and in circulating epithelial cells in patients with intraductal papillary mucinous neoplasms—an observational pilot study

2024-9-1

Shifting the paradigm in personalized cancer care through next‐generation therapeutics and computational pathology

2024-8-30

<scp>APOBEC</scp>3<scp>C</scp>‐mediated <scp>NF</scp>‐κ<scp>B</scp> activation enhances clear cell renal cell carcinoma progression

2024-8-26

Expression of Concern: T‐<scp>LAK</scp> cell‐originated protein kinase (<scp>TOPK</scp>): an emerging prognostic biomarker and therapeutic target in osteosarcoma

2024-8-22

Unravelling the mosaic: Epigenetic diversity in glioblastoma

2024-8-15

Copy number variations contribute to malignant tumor development in children with serious birth defects

2024-8-14

Cell‐free and extracellular vesicle <scp>microRNAs</scp> with clinical utility for solid tumors

2024-8-11

Functional loss of <scp>ERBB</scp> receptor feedback inhibitor 1 (<scp>MIG6</scp>) promotes glioblastoma tumorigenesis by aberrant activation of epidermal growth factor receptor (<scp>EGFR</scp>)

2024-8-11

Inhibition of autophagy as a novel treatment for neurofibromatosis type 1 tumors

2024-8-11

The mevalonate pathway contributes to breast primary tumorigenesis and lung metastasis

2024-8-9

Transcription factor 4 is a key mediator of oncogenesis in neuroblastoma by promoting <scp>MYC</scp> activity

2024-8-9

Cell‐free <scp>DNA</scp> from ascites identifies clinically relevant variants and tumour evolution in patients with advanced ovarian cancer

2024-8-8

Loss of <i>Lkb1</i> cooperates with <i>Braf^V600E</i> and ultraviolet radiation, increasing melanoma multiplicity and neural‐like dedifferentiation

2024-8-8

Precision Cancer Medicine 2.0—Oncology in the postgenomic era

2024-8-7

A comparative study of circulating tumor cell isolation and enumeration technologies in lung cancer

2024-8-6

Dynamic methylation and expression of alternative promoters for oestrogen receptor alpha in cell line models of fulvestrant resistance

2024-8-6

Assessments of prostate cancer cell functions highlight differences between a pan‐<scp>PI</scp>3<scp>K</scp>/m<scp>TOR</scp> inhibitor, gedatolisib, and single‐node inhibitors of the <scp>PI</scp>3<scp>K</scp>/<scp>AKT</scp>/m<scp>TOR</scp> pathway

2024-8-2

A novel <scp>TA</scp>p73‐inhibitory compound counteracts stemness features of glioblastoma stem cells

2024-8-1

Issue Information

2024-8-1

Septin 9 expression regulates ‘don't eat me’ signals and identifies an immune–epithelial class of intrahepatic cholangiocarcinoma

2024-7-31

The genetic duet of concurrent <i>RASAL1</i> and <i>PTEN</i> alterations promotes cancer aggressiveness by cooperatively activating the <scp>PI3K</scp>–<scp>AKT</scp> pathway

2024-7-20

<i>ERBB2</i> mutations define a subgroup of endometrial carcinomas associated with high tumor mutational burden and the microsatellite instability‐high (<scp>MSI</scp>‐H) molecular subtype

2024-7-19

Sustained cancer‐relevant alternative <scp>RNA</scp> splicing events driven by <scp>PRMT5</scp> in high‐risk neuroblastoma

2024-7-17

Circulating tumor cells in metastatic breast cancer patients treated with immune checkpoint inhibitors – a biomarker analysis of the <scp>ALICE</scp> and <scp>ICON</scp> trials

2024-7-8

<scp>PRRX1</scp> silencing is required for metastatic outgrowth in melanoma and is an independent prognostic of reduced survival in patients

2024-7-8

Alternative endpoints to mortality in cancer screening trials

2024-7-6

Detection of colorectal‐cancer‐associated bacterial taxa in fecal samples using next‐generation sequencing and 19 newly established q<scp>PCR</scp> assays

2024-7-6

Importin subunit beta‐1 mediates <scp>ERK5</scp> nuclear translocation, and its inhibition synergizes with <scp>ERK5</scp> kinase inhibitors in reducing cancer cell proliferation

2024-7-4

Immune evasion: An imperative and consequence of <scp>MYC</scp> deregulation

2024-7-2

Circulating tumor cells: advancing personalized therapy in small cell lung cancer patients

2024-7-2

Issue Information

2024-7-1

<b>RETRACTION</b>: The Sp1/<scp>FOXC1</scp>/<scp>HOTTIP</scp>/<scp>LATS2</scp>/<scp>YAP</scp>/β‐catenin cascade promotes malignant and metastatic progression of osteosarcoma

2024-7-1

<b>RETRACTION:</b> CircRNA EPHB4 modulates stem properties and proliferation of gliomas via sponging miR‐637 and up‐regulating SOX10

2024-7-1

A combination of protein phosphatase <scp>2A</scp> inhibition and checkpoint immunotherapy: a perfect storm

2024-6-26

Endometrioid ovarian carcinoma landscape: pathological and molecular characterization

2024-6-25

Metabolic dialogues: regulators of chimeric antigen receptor T cell function in the tumor microenvironment

2024-6-22

Slow‐replicating leukemia cells represent a leukemia stem cell population with high cell‐surface <scp>CD74</scp> expression

2024-6-22

From bedside to bench: New insights in epilepsy‐associated tumors based on recent classification updates and animal models on brain tumor networks

2024-6-20

Current status of precision oncology in adult glioblastoma

2024-6-20